Personalized Cell Therapies Market: By Cell Type (Hematopoietic Stem Cell, Skeletal Muscle Stem Cell, Mesenchymal Stem Cells, Lymphocytes, Others), By Application (Cardiovascular Disorders, Diabetes, Neurological Disorders, Cancer, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Personalized Cell Therapies Market size was valued at USD 12,252.24 million in 2023 and is poised to grow at a CAGR of 23.6% from 2024-2030. Research & Development is evolving, various cell types developed into treatments as novel cell therapies due to its potential applications. Bone marrow transplant or hematopoietic stem cell transplant widely used cell therapy due to the treatment of blood cancer. Increased prevalence of cancer, a rise in research and adoption of advanced technologies are expected attract the demand for the market.

This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers engaged in the manufacturing and supply of personalized cell therapies.

Personalized Cell Therapies Market Key Development:
  • On August 19, 2016, the European Commission has granted conditional marketing authorization for Zalmoxis, patient-specific adjunctive treatment in haploidentical hematopoietic stem cell transplantation for adults with hematological malignancies.  

Global Personalized Cell Therapies Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

23.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Personalized Cell Therapies Market Dynamics

The rise in prevalence of chronic disorders and unmet needs in current treatment methods are expected to catapult the personalized cell therapies market. Increasing prevalence of various disorders such as diabetes, cancer, autoimmune disorders, neurovascular disorders is expected to create demand for personalized cell therapies market over the forecast period. Moreover, potential applications of cell therapies include treating autoimmune disease, cancers, infectious disease, urinary problems, spinal cord injuries, rebuilding damaged cartilage in joints, improving a weakened immune system, neurological disorders are expected to create lucrative opportunities for the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Personalized Cell Therapies Market Segmentation

By Cell Type
  • Hematopoietic Stem Cell
  • Skeletal Muscle Stem Cell
  • Mesenchymal Stem Cells
  • Lymphocytes
  • Others
By Application
  • Cardiovascular Disorders
  • Diabetes
  • Neurological Disorders
  • Cancer
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The personalized cell therapies market size was valued at USD 12,252.24 million in 2023

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

PCT Cell Therapy Services, LLC (U.S) S. Stem Cell, Inc. (U.S) Bellicum Pharmaceuticals, Inc. (U.S) Saneron CCEL Therapeutics, Inc. (U.S) StemGenex (U.S)

1.Executive Summary
2.Global Personalized Cell Therapies Market Introduction 
2.1.Global Personalized Cell Therapies Market  - Taxonomy
2.2.Global Personalized Cell Therapies Market  - Definitions
2.2.1.Cell Type
2.2.2.Application
2.2.3.Region
3.Global Personalized Cell Therapies Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Personalized Cell Therapies Market Analysis, 2019-2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Personalized Cell Therapies Market  By Cell Type, 2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Hematopoietic Stem Cell
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Skeletal Muscle Stem Cell
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Mesenchymal Stem Cells
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Lymphocytes
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Personalized Cell Therapies Market  By Application, 2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cardiovascular Disorders
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diabetes
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Neurological Disorders
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Cancer
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Personalized Cell Therapies Market  By Region, 2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Cell Type Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Hematopoietic Stem Cell
8.1.2.Skeletal Muscle Stem Cell
8.1.3.Mesenchymal Stem Cells
8.1.4.Lymphocytes
8.1.5.Others
8.2.  Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Cardiovascular Disorders
8.2.2.Diabetes
8.2.3.Neurological Disorders
8.2.4.Cancer
8.2.5.Others
8.3.  Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hematopoietic Stem Cell
9.1.2.Skeletal Muscle Stem Cell
9.1.3.Mesenchymal Stem Cells
9.1.4.Lymphocytes
9.1.5.Others
9.2.  Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cardiovascular Disorders
9.2.2.Diabetes
9.2.3.Neurological Disorders
9.2.4.Cancer
9.2.5.Others
9.3.  Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
9.3.7.
10.Asia Pacific (APAC) Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hematopoietic Stem Cell
10.1.2.Skeletal Muscle Stem Cell
10.1.3.Mesenchymal Stem Cells
10.1.4.Lymphocytes
10.1.5.Others
10.2.  Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cardiovascular Disorders
10.2.2.Diabetes
10.2.3.Neurological Disorders
10.2.4.Cancer
10.2.5.Others
10.3.  Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hematopoietic Stem Cell
11.1.2.Skeletal Muscle Stem Cell
11.1.3.Mesenchymal Stem Cells
11.1.4.Lymphocytes
11.1.5.Others
11.2.  Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cardiovascular Disorders
11.2.2.Diabetes
11.2.3.Neurological Disorders
11.2.4.Cancer
11.2.5.Others
11.3.  Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Cell Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hematopoietic Stem Cell
12.1.2.Skeletal Muscle Stem Cell
12.1.3.Mesenchymal Stem Cells
12.1.4.Lymphocytes
12.1.5.Others
12.2.  Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cardiovascular Disorders
12.2.2.Diabetes
12.2.3.Neurological Disorders
12.2.4.Cancer
12.2.5.Others
12.3.  Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.PCT Cell Therapy Services, LLC (U.S)
13.2.2.S. Stem Cell, Inc. (U.S)
13.2.3.Bellicum Pharmaceuticals, Inc. (U.S)
13.2.4.Saneron CCEL Therapeutics, Inc. (U.S)
13.2.5.StemGenex (U.S)
13.2.6.Vericel Corporation.(U.S)
13.2.7.Cytori Therapeutics Inc.(U.S.)
13.2.8.MolMed S.p.A. (Italy)
14. Research Methodology 
15. Appendix and Abbreviations 
  • PCT Cell Therapy Services, LLC (U.S)
  • S. Stem Cell, Inc. (U.S)
  • Bellicum Pharmaceuticals, Inc. (U.S)
  • Saneron CCEL Therapeutics, Inc. (U.S)
  • StemGenex (U.S)
  • Vericel Corporation.(U.S)
  • Cytori Therapeutics Inc.(U.S.)
  • MolMed S.p.A. (Italy)

Adjacent Markets